Dohj LLC Sells 1,223 Shares of The Procter & Gamble Company (NYSE:PG)

Dohj LLC lowered its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 16.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 6,171 shares of the company’s stock after selling 1,223 shares during the quarter. Dohj LLC’s holdings in Procter & Gamble were worth $904,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in PG. Dfpg Investments LLC boosted its position in Procter & Gamble by 1.7% during the 4th quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock valued at $3,680,000 after buying an additional 424 shares during the period. Garrett Wealth Advisory Group LLC boosted its position in Procter & Gamble by 6.3% during the 3rd quarter. Garrett Wealth Advisory Group LLC now owns 4,419 shares of the company’s stock valued at $645,000 after buying an additional 260 shares during the period. Herold Advisors Inc. boosted its position in Procter & Gamble by 2.2% during the 4th quarter. Herold Advisors Inc. now owns 26,592 shares of the company’s stock valued at $3,897,000 after buying an additional 581 shares during the period. N.E.W. Advisory Services LLC boosted its position in Procter & Gamble by 14.6% during the 3rd quarter. N.E.W. Advisory Services LLC now owns 94,424 shares of the company’s stock valued at $13,772,000 after buying an additional 12,016 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in Procter & Gamble by 0.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 16,003,260 shares of the company’s stock valued at $2,298,184,000 after buying an additional 131,339 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of PG stock traded down $1.26 during trading hours on Friday, reaching $161.29. The company had a trading volume of 5,659,784 shares, compared to its average volume of 6,820,118. The business has a fifty day moving average price of $159.64 and a 200-day moving average price of $153.57. The Procter & Gamble Company has a one year low of $141.45 and a one year high of $164.32. The firm has a market cap of $380.67 billion, a PE ratio of 26.35, a price-to-earnings-growth ratio of 3.27 and a beta of 0.44. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm had revenue of $20.20 billion during the quarter, compared to analyst estimates of $20.43 billion. During the same period in the previous year, the business posted $1.37 earnings per share. The business’s revenue for the quarter was up .6% on a year-over-year basis. Sell-side analysts predict that The Procter & Gamble Company will post 6.55 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $1.0065 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.50%. Procter & Gamble’s payout ratio is currently 65.85%.

Insider Transactions at Procter & Gamble

In related news, insider Balaji Purushothaman sold 28,369 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total value of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, insider Balaji Purushothaman sold 28,369 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total value of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction that occurred on Monday, April 22nd. The stock was sold at an average price of $158.50, for a total transaction of $135,517.50. Following the completion of the transaction, the chief executive officer now directly owns 4,004 shares in the company, valued at approximately $634,634. The disclosure for this sale can be found here. Insiders sold 100,865 shares of company stock worth $16,029,280 over the last three months. 0.17% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have recently commented on PG. StockNews.com cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Wells Fargo & Company raised their target price on shares of Procter & Gamble from $162.00 to $170.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 24th. Jefferies Financial Group raised their target price on shares of Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research report on Monday, April 22nd. Argus raised their target price on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Barclays lifted their price target on shares of Procter & Gamble from $168.00 to $170.00 and gave the company an “overweight” rating in a research report on Tuesday, April 23rd. Seven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $169.76.

Read Our Latest Analysis on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.